× Close

The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.

Acta Anaesthesiologica Scandinavica

Identifiers

ISSN 0001-5172
e-ISSN 1399-6576
DOI 10.1111/(ISSN)1399-6576

Additional information

Data set: Wiley

Articles

article

The impact of frailty and rapid response team activation on patients admitted to the intensive care unit: A case‐control matched, observational, single‐centre cohort study

Christopher Dugan, Suzanne Weightman, Vanessa Palmer, Luis Schulz, more

Acta Anaesthesiologica Scandinavica > 68 > 6 > 794 - 802

Background Frailty is a multi‐dimensional syndrome associated with mortality and adverse outcomes in patients admitted to the intensive care unit (ICU). Further investigation is warranted to explore the interplay among factors such as frailty, clinical deterioration triggering a medical emergency team (MET) review, and outcomes following admission to the ICU. Methods Single‐centre, retrospective...
article

Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study

Helene Dalsten, Vera Crone, Jacob Steinmetz, Christine L. Rosager, more

Acta Anaesthesiologica Scandinavica > 68 > 6 > 737 - 744

Background Suxamethonium is hydrolysed by butyrylcholinesterase (BChE) and a low BChE activity can result in a prolonged duration of action of suxamethonium. The BChE activity is reduced during pregnancy and postpartum period by up to 33%. However, it can also be reduced by mutations in the BChE gene. In this study, we assessed BChE activity and mutations in the BChE gene in pregnant and postpartum...
article

Malignant hyperthermia safety – A nationwide survey of publicly funded Swedish healthcare

Anna Hellblom, William Pettersson Miller, Maria Soller, Carolina Samuelsson

Acta Anaesthesiologica Scandinavica > 68 > 6 > 788 - 793

Background Malignant hyperthermia (MH) is a rare pharmacogenetic disorder that can lead to a life‐threatening reaction during general anaesthesia with triggering agents. Prompt life‐saving treatment includes the immediate administration of the antidote dantrolene. This study investigated Swedish healthcare providers' awareness and adherence to guidelines and recommendations with respect to MH and...
view all
journal
thumbnail